Fortitude Family Office’s GoodRx Holdings GDRX Stock Holding History
Bought
Maintained
Sold
Other funds holding GDRX
NFSG
EP
LWM
TWD
ATC
Fortitude Family Office's GDRX Position: Q3 2026 in Review
Fortitude Family Office reduced its GoodRx Holdings (GDRX) stake by 34% in Q3 2026, selling an estimated $503 and leaving 297 shares worth $977. The position accounts for ﹤0.01% of the portfolio, ranked #2255.
Fortitude Family Office first reported a position in GDRX in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.29K in Q2 2026. 10 funds tracked by Wall St. Rank hold GDRX as of Q3 2026.
- Fortitude Family Office held 297 shares of GoodRx Holdings worth $977 as of Q3 2026.
- Fortitude Family Office sold 151 GoodRx Holdings shares in Q3 2026, an estimated $503.
- GoodRx Holdings made up ﹤0.01% of Fortitude Family Office's portfolio in Q3 2026, its #2255 holding.
- Fortitude Family Office first reported a position in GoodRx Holdings in Q2 2025 and has held it in 4 quarters since.
- Fortitude Family Office's GoodRx Holdings position peaked at $1.29K in Q2 2026.
- 10 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2026.
Based on Fortitude Family Office's 13F filing for Q3 2026, filed 14 Oct 2026.